Related references
Note: Only part of the references are listed.Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
Riyad N. H. Seervai et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2022)
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis
Sarah C. Sasson et al.
GASTROENTEROLOGY (2021)
Original Research Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
E. Ghisoni et al.
EUROPEAN JOURNAL OF CANCER (2021)
Expansible residence decentralizes immune homeostasis
Sathi Wijeyesinghe et al.
NATURE (2021)
Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma
J. Randall Patrinely et al.
JAMA ONCOLOGY (2021)
Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota
Djalma S. Lima-Junior et al.
CELL (2021)
Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report
Jacobi Hines et al.
JOURNAL OF MEDICAL CASE REPORTS (2021)
Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review
Nolan J. Maloney et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Long-lasting, irreversible and late-onset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis.
Eleonora Ghisoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The pattern of time to onset and resolution of immune-related adverse events caused by immune checkpoint inhibitors in cancer: A pooled analysis of 23 clinical trials and 8,436 patients.
Si-Qi Tang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
Yves Allenbach et al.
AUTOIMMUNITY REVIEWS (2020)
Immunity to commensal skin fungi promotes psoriasiform skin inflammation
Charlotte Hurabielle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
Kohei Shitara et al.
JAMA ONCOLOGY (2020)
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara et al.
LANCET ONCOLOGY (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combined immune therapy grade IV dermatitis in metastatic melanoma
Manreet Randhawa et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
Pamela C. Rosato et al.
NATURE COMMUNICATIONS (2019)
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
Ichiro Yamauchi et al.
PLOS ONE (2019)
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis
Yucai Wang et al.
JAMA ONCOLOGY (2019)
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S. Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Laboratory mice born to wild mice have natural microbiota and model human immune responses
Stephan P. Rosshart et al.
SCIENCE (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
Michael G. Constantinides et al.
SCIENCE (2019)
Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine
Emma Fixsen et al.
ONCOLOGIST (2019)
Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury
Oliver J. Harrison et al.
SCIENCE (2019)
Microbial guardians of skin health
Apollo Stacy et al.
SCIENCE (2019)
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO plus IPI: a systematic review and meta-analysis
Puyuan Xing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair
Jonathan L. Linehan et al.
CELL (2018)
Understanding Subset Diversity in T Cell Memory
Stephen C. Jameson et al.
IMMUNITY (2018)
Contextual control of skin immunity and inflammation by Corynebacterium
Vanessa K. Ridaura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens A Systematic Review and Meta-analysis
Romualdo Barroso-Sousa et al.
JAMA ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dermatologic Reactions to Immune Checkpoint Inhibitors Skin Toxicities and Immunotherapy
Vincent Sibaud
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Jonathan L. Curry et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy
Hisashi Nomura et al.
JOURNAL OF DERMATOLOGY (2017)
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V. Balar et al.
LANCET ONCOLOGY (2017)
Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome
Sayeef Mirza et al.
MELANOMA RESEARCH (2017)
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Allyson L. Byrd et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Bacterial colonization and succession in a newly opened hospital
Simon Lax et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Stephan P. Rosshart et al.
CELL (2017)
Temporal Stability of the Human Skin Microbiome
Julia Oh et al.
CELL (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Lalit K. Beura et al.
NATURE (2016)
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Gloria B. Choi et al.
SCIENCE (2016)
Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma
Mariam B. Totonchy et al.
JAMA DERMATOLOGY (2016)
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino et al.
JAMA ONCOLOGY (2016)
Tissue-resident memory T cells: local specialists in immune defence
Scott N. Mueller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
J. Naidoo et al.
ANNALS OF ONCOLOGY (2015)
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Jacob S. Lee et al.
IMMUNITY (2015)
A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes
Tiffany C. Scharschmidt et al.
IMMUNITY (2015)
Commensal-dendritic-cell interaction specifies a unique protective skin immune signature
Shruti Naik et al.
NATURE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis
Dezhi Kang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments
Dirk W. Luchtman et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Biogeography and individuality shape function in the human skin metagenome
Julia Oh et al.
NATURE (2014)
Temporal variability is a personalized feature of the human microbiome
Gilberto E. Flores et al.
GENOME BIOLOGY (2014)
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
David A. Martin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses
Timothy W. Hand et al.
SCIENCE (2012)
Compartmentalized Control of Skin Immunity by Resident Commensals
Shruti Naik et al.
SCIENCE (2012)
Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates
Sean Conlan et al.
GENOME BIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Microbial Symbiosis with the Innate Immune Defense System of the Skin
Richard L. Gallo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Microbial Colonization Drives Expansion of IL-1 Receptor 1-Expressing and IL-17-Producing γ/δ T Cells
Jinyou Duan et al.
CELL HOST & MICROBE (2010)
Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity
Nitya Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immune adaptations that maintain homeostasis with the intestinal microbiota
Lora V. Hooper et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
Anna Maria Di Giacomo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Bacterial Community Variation in Human Body Habitats Across Space and Time
Elizabeth K. Costello et al.
SCIENCE (2009)
Increased expression of interleukin 17 in inflammatory bowel disease
S Fujino et al.
GUT (2003)
Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene
Q Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
N Ziolkowska et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
